Dysfunction of mitochondria and oxidative stress in the pathogenesis of Alzheimer's disease: On defects in the cytochrome c oxidase complex and aldehyde detoxification

Journal of Alzheimer's Disease

Volumn 9, Issue 2, 2006, Pages 155-166

  Ohta, Shigeo ^a   Ohsawa, Ikuroh ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Aldehyde; ALDH2; Case control study; Cytochrome c oxidase; DLST

Indexed keywords

ALCOHOL; ALCOHOL DEHYDROGENASE; ALDEHYDE; ALDEHYDE DEHYDROGENASE ISOENZYME 2; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; CYTOCHROME C OXIDASE; DIHYDROLIPOAMIDE SUCCINYLTRANSFERASE; GLUCOSE;

ALCOHOL METABOLISM; ALZHEIMER DISEASE; AUTOPSY; BRAIN MITOCHONDRION; CITRIC ACID CYCLE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON TRANSPORT; ENERGY METABOLISM; ENERGY YIELD; ENZYME ACTIVITY; ENZYME INACTIVATION; EXON; GENETIC MANIPULATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GLUCOSE BRAIN LEVEL; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; NEUROPATHOLOGY; NONHUMAN; ONSET AGE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; RESPIRATORY CHAIN; REVIEW; RISK FACTOR; TRANSGENIC MOUSE;

EID: 33746039656     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2006-9208     Document Type: Review

References (62)

1. S. Ohta, A multi-functional organelle mitochondrion is involved in cell death, proliferation and disease, Curr. Med. Chem. 10 (2003), 2485-2494.
2. R.H. Swerdlow and S.J. Kish, Mitochondria in Alzheimer's disease, Int. Rev. Neurobiol. 53 (2002), 341-385.
3. I. Maurer, S. Zierz and H. Moller, A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients, Neurobiol. Aging 21 (2000), 455-462.
4. S.J. Kish, F. Mastrogiacomo, M. Guttman, Y. Fukukawa, J-W. taanman, S. Dozic, M. Pandolfo, J. Lamarche, L. DiStefano and L.-J. Chang, decreased Brain Protein Levels of Cytochrome Oxidase Subunits in Alzheimer's Diseae and in Herieditary Spinocerebllar Ataxia Disorders. J. Neurochem. 72 (1999), 700-707.
5. W.D. Parker Jr, N.J. Mahr, C.M. Filley, J.K. Parks, D. Hughes, D.A. Young and C.M. Cullum, Reduced platelet cytochrome c oxidase activity in Alzheimer's disease, Neurology 44 (1994), 1086-1090.
6. M. Mancuso, M. Filosto, F. Bosetti, R. Ceravolo, A. Rocchi, G. Tognoni, M.L. Manca, G. Solaini, G. Siciliano and L. Murri, Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease, Exp. Neurol. 182 (2003), 421-426.
7. S.M. Cardoso, M.T. Proenca, S. Santos, I. Santana and C.R. Oliveira, Cytochrome c oxidase is decreased Alzheimer's disease platelets, Neurobiol. Aging 25 (2004), 105-110.
8. T. Szabados, C. Dul, K. Majtényi, J. Hargitai, Z. Pénzes and R. Urbanics, A chronic Alzheimer's model evoked by mitochondrial poison sodium azide for pharmacological investigations, Behav. Brain Res. 154 (2004), 31-40.
9. K. Nakano, S. Matuda, T. Sakamoto, C. Takase, S. Nakagawa, S. Ohta, T. Ariyama, J. Inazawa, T. Abe and T. Miyata, Human dihydrolipoamide succinyltransferase: cDNA cloning and localization on chromosome 14q24.2-q24.3, Biochim Biophys Acta 1216 (1993), 360-368.
10. K. Nakano, S. Ohta, K. Nishimaki, T. Miki and S. Matuda, Alzheimer's disease and DLST genotype, Lancet 350 (1997), 1367-1368.
11. K.F. Sheu, L. Lilius, A. Brown, B. Kristal, V. Haratounian, R. Mohs, N. Relkin, R. Kalaria, H. Basun, L.O. Wahlund, M. Viitanen, L. Lannfelt and J.P. Blass, Polymorphisms of the DLST gene associate with late-onset and with familial Alzheimer's disease, Neurobiol Aging 19 (1998), S293.
12. K.P. Sheu, A.M. Brown, B.S. Kristal, R.N. Kalaria, L. Lilius, L. Lannfelt and J.P. Blass, A DLST genotype associated with reduced risk for Alzheimer's disease, Neurology52 (1999), 1505-1507.
13. H. Kunugi, S. Nanko, A. Ueki, K. Isse and H. Hirasawa, DLST gene and Alzheimer's disese, Lancet 351 (1998), 1584.
14. T. Kanamori, K. Nishimaki, S. Asoh, Y. Ishibashi, I. Takata, T. Kuwabara, K. Taira, H. Yamaguchi, S. Sugihara, T. Yamazaki, Y. Ihara, K. Nakano, S. Matuda and S. Ohta, Truncated product of the bifunctional DLST gene involved in biogenesis of the respiratory chain, EMBO J. 22 (2003), 2913-2923.
15. C.S. Caseley, L. Canevari, J.M. Land, J.B. Clark and M.A. Sharpe, β-amyloid inhibits integrated mitochondrial respiration and key enzyme activity, J. Neurochem. 80 (2002), 91-100.
16. C. Strazielle, C. Sturchler-Pierrat, M. Staufenbiel and R. Lalonde, Regional brain cytochrome oxidase activity in β-amyloid precursor protein transgenic mice with the Swedish mutation, Neuroscience 118 (2003), 1151-1163.
17. P.J. Crouch, R. Blake, J.A. Duce, G.D. Ciccotosto, Q.X. Li, K.J. Barnham, C.C. Curtain, R.A. Cherny, R. Cappai, T. Dyrks, C.L. Masters and I.A. Trounce, Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42, J. Neurosci. 25 (2005), 672-679.
18. F.Y. Teng and B.L. Tang, Widespread gamma-secretase activity in the cell, but do we need it at the mitochondria? Biochem. Biophys. Res. Commun. 328 (2005), 1-5.
19. J.W. Lustbader, M. Cirilli, C. Lin, H.W. Xu, K. Takuma, N. Wang, C. Caspersen, X. Chen, S. Pollak, M. Chaney, F. Trinchese, S. Liu, F. Gunn-Moore, L.F. Lue, D.G. Walker, P. Kuppusamy, Z.L. Zewier, O. Arancio, D. Stern, S.S. Yan and H. Wu, ABAD directly links Aβ to mitochondrial toxicity in Alzheimer's disease, Science 304 (2004), 448-452.
20. K. Takuma, J. Yao, J. Huang, H. Xu, X. Chen, J. Luddy, A.C. Trillat, D.M. Stern, O. Arancio and S.S. Yan, ABAD enhances Aβ-induced cell stress via mitochondrial dysfunction, FASEB J. 19 (2005), 597-622.
21. C. Behl, J.B. Davis, R. Lesley and D. Schubert, Hydrogen peroxide mediates amyloid beta protein toxicity, Cell 77 (1994), 817-827.
22. S. Melov, J.A. Schneider, B.J. Day, D. Hinerfeld, P. Coskun, S.S. Mirra, J.D. Crapo and D.C. Wallace, A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase, Nat. Genet. 18 (1998) 159-163.
23. S. Ohta, I. Ohsawa, K. Kamino, F. Ando and H. Shimokata, Mitochondrial ALDH2 deficiency as an oxidative stress, Ann. NY Acad. Sci. 1011 (2004), 36-44.
24. V. Vasiliou and A. Pappa, Polymorphisms of human aldehyde dehydrogenases. Consequences for drug metabolism and disease, Pharmacology 61 (2000), 192-198.
25. A. Yoshida, I.Y. Huang and M. Ikawa, Molecular abnormality of an inactive aldehyde dehydrogenase variant commonly found in Orientals, Proc. Natl. Acad. Sci. USA 81 (1984), 258-261.
26. H.N. Larson, H. Weiner and T.D. Hurley, Disruption of the coenzyme binding site and dimer interface revealed in the crystal structure of mitochondrial aldehyde dehydrogenase "Asian" variant, J. Biol. Chem. 280 (2005), 30550-30556.
27. T. Takeshita, K. Morimoto, X. Mao, T. Hashimoto and J. Furuyama, Characterization of the three genotypes of low Km aldehyde dehydrogenase in a Japanese population, Hum. Genet. 94 (1994), 217-223.
28. K. Kamino, K. Nagasaka, M. Imagawa, H. Yamamoto, H. Yoneda, A. Ueki, S. Kitamura, K. Namekata, T. Miki and S. Ohta, Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population, Biochem. Biophys. Res. Commun. 273 (2000), 192-196.
29. J.M. Kim, R. Stewart, I.S. Shin, J.S. Jung and J.S. Yoon, Assessment of association between mitochondrial aldehyde dehydrogenase polymorphism and Alzheimer's disease in an older Korean population, Neurobiol. Aging 25 (2004), 295-301.
30. H.W. Goedde, D.P. Agarwal, G. Fritze, D. Meier-Tackmann, S. Singh, G. Beckmann, K. Bhatia, L.Z. Chen, B. Fang, R. Lisker et al., Distribution of ADH2 and ALDH2 genotypes in different populations, Hum. Genet. 88 (1992), 344-346.
31. Y. Suzuki, T. Muramatsu, M. Taniyama, Y. Atsumi, M. Suematsu, R. Kawaguchi, S. Higuchi, T. Asahina, C. Murata, M. Handa and K. Matsuoka, Mitochondrial aldehyde dehydrogenase in diabetes associated with mitochondrial tRNA(Leu(UUR)) mutation at position 3243, Diabetes Care 19 (1996), 1423-1425.
32. A. Yokoyama, T. Muramatsu, T. Ohmori, T. Yokoyama, K. Okuyama, H. Takahashi, Y. Hasegawa, S. Higuchi, K. Maruyama, K. Shirakura and H. Ishii, Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics, Carcinogenesis 19 (1998), 1383-1387.
33. S. Takagi, S. Baba, N. Iwai, M. Fukuda, T. Katsuya, J. Higaki, T. Mannami, J. Ogata, Y. Goto and T. Ogihara, The aldehyde dehydrogenase 2 gene is a risk factor for hypertension in Japanese but does not alter the sensitivity to pressor effects of alcohol: the Suita study, Hypertens. Res. 24 (2001), 365-370.
34. K. Amamoto, T. Okamura, S. Tamaki, Y. Kita, Y. Tsujita, T. Kadowaki, Y. Nakamura and H. Ueshima, Epidemiologic study of the association of low-Km mitochondrial acetaldehyde dehydrogenase genotypes with blood pressure level and the prevalence of hypertension in a general population, Hypertens. Res. 25 (2002), 857-864.
35. H. Shimokata, F. Ando and N. Niino, A new comprehensive study on aging-the National Institute for Longevity Sciences, Longitudinal Study of Aging (NILS-LSA), J. Epidemiol. 10 (2000), S1-S9.
36. H. Shimokata, Y. Yamada, M. Nakagawa, R. Okubo, T. Saido, A. Funakoshi, K. Miyasaka, S. Ohta, G. Tsujimoto, M. Tanaka, F. Ando and N. Niino, Distribution of geriatric disease-related genotypes in the National Institute for Longevity Sciences, Longitudinal Study of Aging (NILS-LSA), J. Epidemiol. 10 (2000), S46-S55.
37. I. Ohsawa, K. Kamino, K. Nagasaka, F. Ando, N. Niino, H. Shimokata and S. Ohta, Genetic deficiency of a mitochondrial aldehyde dehydrogenase increases serum lipid peroxides in community-dwelling females, J. Hum. Genet. 48 (2003), 404-409.
38. K. Uchida and E.R. Stadtman, Modification of histidine residues in proteins by reaction with 4-hydroxynonenal, Proc. Natl. Acad. Sci. USA 89 (1992), 4544-4548.
39. W.G. Siems, S.J. Hapner and F.J. van Kuijk, 4-hydroxynonenal inhibits Na(+)-K(+)-ATPase, Free Radic. Biol. Med. 20 (1996), 215-223.
40. I.I. Kruman and M.P. Mattson, Pivotal role of mitochondrial calcium uptake in neural cell apoptosis and necrosis, J. Neurochem. 72 (1999), 529-540.
41. T.J. Montine, M.D. Neely, J.F. Quinn, M.F. Seal, W.R. Markesbery, L.J. Roberts and J.D. Morrow, Lipid peroxidation in aging brain and Alzheimer's disease, Free Radic. Biol. Med. 33 (2002), 620-626.
42. A. Yoritaka, N. Hattori, K. Uchida, M. Tanaka, E.R. Stadtman and Y. Mizuno, Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease, Proc. Natl Acad. Sci. USA 93 (1996), 2696-2701.
43. L.M. Sayre, D.A. Zelasko, P.L. Harris, G. Perry, R.G. Salomon and M.A. Smith, 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease, J. Neurochem. 68 (1997), 2092-2097.
44. I. Ohsawa, K. Nishimaki, C. Yasuda, K. Kamino and S. Ohta, Deficiency in a mitochondrial aldehyde dehydrogenase increases vulnerability to oxidative stress in PC12 cells, J. Neurochem. 84 (2003), 1110-1117.
45. S.E. Schriner, N.J. Linford, G.M. Martin, P. Treuting, C.E. Ogburn, M. Emond, P.E. Coskun, W. Ladiges, N. Wolf, H. Van Remmen, D.C. Wallace and P.S. Rabinovitch, Extension of murine life span by overexpression of catalase targeted to mitochondria, Science 308 (2005), 1909-1911.
46. K. Kitagawa, T. Kawamoto, N. Kunugita, T. Tsukiyama, K. Okamoto, A. Yoshida, K. Nakayama and K. Nakayama, Aldehyde dehydrogenase (ALDH) 2 associates with oxidation of methoxyacetaldehyde; in vitro analysis with liver subcellular fraction derived from human and Aldh2 gene targeting mouse, FEBS Lett. 476 (2000), 306-311.
47. T.I. Williams, B.C. Lynn, W.R. Markesbery and M.A. Lovell, Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease, Neurobiol. Aging (2005), (Epub head of print).
48. D. Pratico, C.M. Clark, F. Liun, J. Rokach, V.Y. Lee and J.Q. Trojanowski, Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease, Arch. Neurol. 59 (2002), 972-976.
49. W.A. Pedersen, N.R. Cashman and M.P. Mattson, The lipid peroxidation product 4-hydroxynonenal impairs glutamate and glucose transport and choline acetyltransferase activity in NSC-19 motor neuron cells, Exp. Neurol. 155 (1999), 1-10.
50. M.D. Neely, K.R. Sidell, D.G. Graham and T.J. Montine, The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin, J. Neurochem. 72 (1999), 2323-2333.
51. K. Zarkovic, 4-hydroxynonenal and neurodegenerative diseases, Mol. Aspects Med. 24 (2003), 293-303.
52. A. Takeda A, M.A. Smith, J. Avila, A. Nunomura, S.L. Siedlak, X. Zhu, G. Perry and L.M. Sayre, In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification, J. Neurochem. 75 (2000), 1234-1241.
53. Q. Liu, M.A. Smith, J. Avila, J. DeBernardis, M. Kansal, A. Takeda, X. Zhu, A. Nunomura, K. Honda, P.I. Moreira, C.R. Oliveira, M.S. Santos, S. Shimohama, G. Aliev, J. de la Torre, H.A. Ghanbari, S.L. Siedlak, P.L. Harris, L.M. Sayre and G. Perry, Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations. Free Radic. Biol. Med. 38 (2005), 746-754.
54. E. Tamagno, M. Parola, P. Bardini, A. Piccini, R. Borghi, M. Guglielmotto, G. Santoro, A. Davit, O. Danni, M.A. Smith, G. Perry and M. Tabaton, Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways, J. Neurochem. 92 (2005), 628-636.
55. D. Pratico, K. Uryu, S. Leight, J.Q. Trojanoswki and V.M. Lee, Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis, J. Neurosci. 21 (2001), 4183-4187.
56. K.S. Montine, S.J. Olson, V. Amarnath, W.O. Whetsell Jr., D.G. Graham and T.J. Montine, Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4, Am. J. Pathol. 150 (1997), 437-443.
57. W.A. Pedersen, S.L. Chan and M.P. Mattson, A mechanism for the neuroprotective effect of apolipoprotein E: isoform-specific modification by the lipid peroxidation product 4-hydroxynonenal, J. Neurochem. 74 (2000), 1426-1433.
58. H.L. Rittner, V. Hafner, P.A. Klimiuk, L.I. Szweda, J.J. Goronzy and C.M. Weyand, Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis, J. Clin. Invest. 103 (1999), 1007-1013.
59. J.S. White and K.R. Rees, The mechanism of action of 4-hydroxynonenal in cell injury, Chem. Biol. Interact. 52 (1984), 233-241.
60. Y. Suzuki, M. Fujisawa, F. Ando, N. Niino, I. Ohsawa, H. Shimokata and S. Ohta, Alcohol dehydrogenase 2 variant is associated with cerebral infarction and lacunae, Neurology 63 (2004), 1711-1713.
61. D.P. Hartley, J.A. Ruth and D.R. Petersen, The hepatocellular metabolism of 4-hydroxynonenal by alcohol dehydrogenase, aldehyde dehydrogenase, and glutathione S-transferase, Arch. Biochem. Biophys. 316 (1995), 197-205.
62. T.C. Murphy, V. Amarnath, K.M. Gibson and M.J. Picklo Sr, Oxidation of 4-hydroxy-2-nonenal by succinic semialdehyde dehydrogenase (ALDH5A), J. Neurochem. 86 (2003), 298-305.